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Dr. Miettinen has called for a debate on his ideas about the
single etiologic study and the use of trial data for the
construction of smooth-in-time risk prediction functions
[1]. He did so admittedly as an attempt to inﬂuence the
possible achievement of a paradigm shift.
Dr. Miettinen is one of the founding fathers of modern
epidemiology. Many of the concepts and terms he has
introduced have found their way into current epidemio-
logical thinking and discourse, respectively. Why has the
same not yet happened with his ideas on the single etio-
logic study and with the signiﬁcance of this new paradigm
for intervention-prognostic research? Dr. Miettinen won-
ders and so do presumably many of those who have made a
serious effort to study his writings. Although the roots of
the single etiologic study can be traced back to Miettinen’s
1985 book [2], the formal concept is a bit more recent than
the other concepts that are already accepted in epidemiol-
ogy. So is it simply a matter of time? It might well be, but
Dr. Miettinen’s concern is to change the’prognostic proﬁle’
by opening a debate, which is fair enough and offers an
exciting prospect. Remarkably, Pearl, a founder of modern
causal theories with wide potential for implementation
notably theories and methods of structural causal model-
ling, recently noted a similar difﬁculty in getting the
message down to the masses. His attempt to solution was to
produce an article aimed at making the recent advances
more accessible through a ‘gentle introduction’ to the
generally unfamiliar complexities of methods such as path
analysis [3]. What we are seeing in both cases is a need for
highly complex theory to marry with didactics and dis-
semination strategy. This could mean incorporation into a
pedagogical framework that enables future students of
epidemiology to embrace this shift for inclusion into
mainstream applications.
Epidemiology Journals currently form an important part
of the pedagogical framework for epidemiology students.
Therefore, in the hope of contributing something to the
inception of the debate we would like to ask Dr. Miettinen
some questions here about the single etiologic study and its
relevance to trial analysis. One of the passages that struck
us in the recent paper is where Dr. Miettinen insists that the
single etiologic study should not be presented as a uniﬁ-
cation of the traditional cohort and case–control studies,
but that it is a design that differs from both and that should
replace any old one. This made us wonder: can or should
old etiologic study data be re-analysed in the spirit of the
single etiognostic study? If so, would the results in terms of
rate ratios be any different, or, when are they expected to
be different and why? In the event, would it be possible to
provide a practical step-by-step example of how to re-
analyse data from a traditional observational follow-up
study? If it turns out that re-analysis would be a good idea
in more than a minimal proportion of old studies, this could
have an enormous impact on epidemiological practice in
the coming decennia.
Our own tentative answer is that, yes, re-analysis can
often be envisaged because documented population time
(in terms of exposure histories) of both study base and of
cases arising from it will often be available, whether the
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‘nested case–control’ or ‘cohort’ type. We have no full
insight into the procedures needed but we think that there
may be two main keys. The ﬁrst of those is the different
handling of etiologic time, which, in the single etiologic
study of Miettinen, is negative as from the time of mani-
festation of case status i.e. as from time of ﬁrst manifes-
tation of case-deﬁning status in cases, and, end of
individual follow-up time in non-cases. This different
handling is needed also if the old study was based on a
cohort with a planned ﬁxed individual follow-up period.
The reversal of etiologic time during re-analysis of tradi-
tional cohort data then leads to a situation where the
exposure data become left-censored instead of right-cen-
sored. The second main key to re-analysis may be the (re-
)sampling from the study base for the formation of a ref-
erence series, which should never be restricted to the non-
case domain, and again this would need to hold for re-
analysis of all ‘old types of design’.
Another question we have relates to the desideratum,
mentioned in the recent paper [1], for the case series to be
much smaller than the reference series in the suggested
additional analysis of trial data. What would be a good
operational deﬁnition of ‘much smaller’ in these matters?
We think that, especially in smaller trials, the outcome is
often a relatively frequent event (in terms of incidence) so
that the base will not be that much bigger than the case
series? Would there be any recommended approach to
constructing a prognostic function in such instances? On
the matter of advancing the quality of intervention studies
we agree that the paradigm of the single etiognostic study
would not only advance quality but also cost efﬁcient use
of the research infrastructure invested in intervention
studies. Questions here revolve around how best to
abstract the base series, bearing in mind both left- and
right censoring of the ‘source population’ in intervention
studies.
As always, the ideas of Dr. Miettinen are well worth
studying and debating. We are thrilled by the prospect of
an interesting debate but, for many, (examples of) imple-
mentation will be a condition for deeper understanding.
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Professor Miettinen Replies:
To propose, as I did [1], a paradigm shift in our thinking
about ideal etiologic and intervention studies—in what we
take to be the essence of each of these—is to say something
that inherently invites a response from any critical teacher
of epidemiological research. The implicit questions to any
such teacher were: Will you start teaching the etiologic
study as the necessary replacement for ‘cohort’ and ‘case–
control’ studies? and: will you teach the use of this study
structure on the (usual type of) data from intervention trials
– with the proposed, novel variant of logistic regression
replacing Cox regression and leading to prognostic prob-
ability functions? Before answering these questions, how-
ever, such a teacher may well see the need to have me
answer some questions of theirs.
I was, thus, astonished and disappointed to ﬁnd that the
initial response to my explicit (sic) call for public discourse
on these matters in this journal was a single Letter to the
Editor.
In that Letter, Van den Broeck et alii [2] seem to
implicitly express agreement with what I said about etio-
logic and intervention studies. But they describe my
propositions as constituting a ‘highly complex theory,’
presenting notable challenges for didactics and other dis-
semination; and they thus ask two didactics-related ques-
tions about it: ‘[C]an or should old etiologic study data be
re-analysed in the spirit of the single etiognostic study?’
and ‘What would be a good operational deﬁnition of
[suitably large for the base series relative to the size of the
case series in the proposed type of logistic regression on
data from intervention trials]?’
To these colleagues I say, for orientation, that I regard
‘highly complex theory’ as much too grandiose a charac-
terization of the novelties I advocate.
‘Re-analyses’ of data from already-published ‘cohort’
studies would be feasible and instructive; and they would
be particularly valuable in the context of studies in which,
as is usual, the source-cohort’s follow-up is of long (and
hence variable) duration. To be borne in mind in these is
that the population-time of the cohort’s follow-up consti-
tutes only the source base, and that therefore the ﬁrst-stage
case and base series from it need to be reduced to those
from the actual study base (each person-moment in it
actually representing the domain of the object of study and
presence of one of the contrasted histories). The translation
of ‘cohort’ studies to genuine etiologic studies is fully
instructive of the general essence (singular) of etiologic
studies, including in the context of dynamic source popu-
lations: commitment to a source population, speciﬁcally to
the source base formed by its course over a particular span
of time; etc.
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ologic study with a cohort-type source population or from
an intervention trial, the contextual point of note is that
there is no material cost (marginal) to however large an
expansion of the base series. Hence, it should be made
large-enough to abstract practically all of the (comparative)
information in the study base. A 100-fold sample already is
suitably large, a 1,000-fold sample better to an immaterial
extent.
Concerning their Letter, Van Den Broeck et alii express
‘the hope of contributing something to the inception of the
[public discourse]’; and they do just that, uniquely. I thank
them for this and very much hope others will follow
their example, whether spontaneously or by the Editor’s
solicitation.
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